Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

ceva santé animale - live attenuated infectious bronchitis (ib) virus, strain 1/96, variant subtype - lyophilisate for oculonasal suspension/use in drinking water - . - avian infectious bronchitis virus - chickens - immunological - live vaccine

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

ceva-phylaxia veterinary biologicals co. ltd - live attenuated infectious bronchitis disease virus, massachusetts type, strain b48 - lyophilisate for oculonasal suspension/use in drinking water - . - avian infectious bronchitis virus - chickens - immunological - live vaccine

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpesirus, live - suspension and solvent for suspension for injection - . - avian herpes virus (marek's disease) - chickens - immunological - live vaccine

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - erlotinib hydrochloride, quantity: 163.93 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; magnesium stearate; sodium lauryl sulfate; lactose monohydrate; titanium dioxide; hypromellose; hyprolose; macrogol 400 - non-small cell lung cancer: tarceva is indicated for the first-line treatment of patients with advanced (stage iiib) or metastatic (stage iv) non-small cell lung cancer (nsclc) with activating egfr mutations. tarceva is indicated for maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating egfr mutations who have not progressed on first-line chemotherapy. tarceva is also indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior chemotherapy. pancreatic cancer: tarceva in combination with gemcitabine is indicated for the treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - erlotinib hydrochloride, quantity: 109.29 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; sodium starch glycollate; microcrystalline cellulose; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; hyprolose; macrogol 400 - non-small cell lung cancer: tarceva is indicated for the first-line treatment of patients with advanced (stage iiib) or metastatic (stage iv) non-small cell lung cancer (nsclc) with activating egfr mutations. tarceva is indicated for maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating egfr mutations who have not progressed on first-line chemotherapy. tarceva is also indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior chemotherapy. pancreatic cancer: tarceva in combination with gemcitabine is indicated for the treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - erlotinib hydrochloride, quantity: 27.32 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; lactose monohydrate; sodium lauryl sulfate; sodium starch glycollate; titanium dioxide; hypromellose; hyprolose; macrogol 400 - non-small cell lung cancer: tarceva is indicated for the first-line treatment of patients with advanced (stage iiib) or metastatic (stage iv) non-small cell lung cancer (nsclc) with activating egfr mutations. tarceva is indicated for maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating egfr mutations who have not progressed on first-line chemotherapy. tarceva is also indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior chemotherapy. pancreatic cancer: tarceva in combination with gemcitabine is indicated for the treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

ceva-phylaxia veterinary biologicals co. ltd - marek's disease virus strain cvi 988 live - concentrate and solvent for suspension for injection - 800-5000 plaque forming unit - avian herpes virus (marek's disease)

Kanada - inglise - Health Canada

ceva animal health inc - ceftiofur (ceftiofur hydrochloride) - suspension - 50mg - ceftiofur (ceftiofur hydrochloride) 50mg - cattle; swine (pigs)

Saudi Araabia - inglise - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

ceva santé animale, france - ceftiofur hydrochloride - suspension for injection - 50 mg/ml

Kenya - inglise - Pharmacy and Poisons Board

ceva santÉ animale 10 avenue de la ballastière, 33500 libourne. - ceftiofur (as hydrochloride) - solution for injection - ceftiofur (as hydrochloride) .. 50mg/ml - third-generation cephalosporins